Cancer clinical trials in the region Centre-Val de Loire

50 currently recruiting clinical trials
Region Centre-Val de Loire

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized ALK None Systemic Treatment-Naive Surgery
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR
Bristol-Myers Squibb
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
AstraZeneca
Phase 3 Lymphoma
#NCT06508658
B cell lymphoma Large B cell lymphoma None CD20 Chemotherapy Monoclonal antibodies
Systemic Treatment-Naive Bispecific T-cell engager antibodies
Centre Hospitalier Régional Universitaire de Tours (Tours)
Genmab
Phase 3 Lymphoma CLL & Richter's syndrome
#NCT06428019
B cell lymphoma CLL (Chronic Lymphocytic Leukemia) Lymphocytic lymphoma > 60 ml/min 50-60 ml/min 30-50 ml/min Systemic Treatment-Naive
Centre Hospitalier Régional d'Orléans Hôpital de La Source (Orléans)
Abbvie
Phase 3 Lung cancer
#NCT05899608
NSCLC (Non-Small Cell Lung Cancer) Squamous NSCLC Non-squamous NSCLC Metastatic Systemic Treatment-Naive
Centre Hospitalier Régional Universitaire de Tours (Tours)
Summit Therapeutics
Phase 3 Prostate cancer
#NCT06120491
Metastatic Hormone-sensitive Surgery Radiotherapy Systemic Treatment-Naive
Centre Hospitalier Régional Universitaire de Tours (Tours)
AstraZeneca